Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal
Tiziana Life Sciences Ltd. (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug ...